Undisclosed Antibody Program(s)

About Novici Biotech

Novici Biotech is a preclinical-stage biotech firm specializing in the discovery and development of antibody and biologic therapeutics. The company employs a proprietary technology platform to engineer proteins with enhanced properties, targeting areas of high unmet medical need. As a private entity, it operates with a lean structure and is likely funded through venture capital and partnerships. Its strategy involves advancing internal pipeline candidates while potentially engaging in collaborative research and licensing deals to generate value.

About Avesta76 Therapeutics

Avesta76 Therapeutics is an early-stage oncology biotech startup aiming to redefine cancer care by developing therapeutics that promise a new standard of hope, potentially through enhanced safety profiles. Operating since 2016, the company is in the preclinical or discovery phase, building its pipeline and technology platform without yet generating revenue. As a private entity, its success hinges on advancing its research, securing venture funding, and translating its scientific vision into viable clinical candidates for a wide range of cancers.

Therapeutic Areas